Lv3
348 积分 2024-07-16 加入
Engineered natural killer cells for cancer therapy
1天前
待确认
Immune modulation by butyrophilins
7天前
已完结
NKG2D ligands in glioma stem-like cells: expression in situ and in vitro
7天前
已完结
Chimeric antigen receptor T cell therapy: 25years in the making
13天前
已完结
CAR T-cell therapies in China: rapid evolution and a bright future
13天前
已完结
Development and Maintenance of Regulatory T cells
18天前
已完结
Regulatory T Cells and Immune Tolerance
18天前
已完结
Regulatory T Cells and Immune Tolerance
18天前
已完结
Foxp3-dependent programme of regulatory T-cell differentiation
18天前
已完结
Foxp3+ regulatory T cells: differentiation, specification, subphenotypes
18天前
已完结
皖公网安备34019202002308
